Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapport Therapeutics (RAPP) Capital Expenditures (2023 - 2026)

Rapport Therapeutics (RAPP) has 4 years of Capital Expenditures data on record, last reported at $86000.0 in Q1 2026.

  • On a quarterly basis, Capital Expenditures fell 70.45% to $86000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $411000.0, a 74.69% decrease, with the full-year FY2025 number at $616000.0, down 74.39% from a year prior.
  • Capital Expenditures reached $86000.0 in Q1 2026 per RAPP's latest filing, down from $169000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for RAPP hit a ceiling of $1.4 million in Q4 2023 and a floor of $22000.0 in Q2 2025.
  • A 4-year average of $417818.2 and a median of $169000.0 in 2025 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: skyrocketed 169.23% in 2024, then plummeted 97.72% in 2025.
  • Tracing RAPP's Capital Expenditures over 4 years: stood at $1.4 million in 2023, then plummeted by 84.27% to $226000.0 in 2024, then decreased by 25.22% to $169000.0 in 2025, then crashed by 49.11% to $86000.0 in 2026.
  • Business Quant data shows Capital Expenditures for RAPP at $86000.0 in Q1 2026, $169000.0 in Q4 2025, and $134000.0 in Q3 2025.